FR2046M - Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration. - Google Patents

Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.

Info

Publication number
FR2046M
FR2046M FR902231A FR902231A FR2046M FR 2046 M FR2046 M FR 2046M FR 902231 A FR902231 A FR 902231A FR 902231 A FR902231 A FR 902231A FR 2046 M FR2046 M FR 2046M
Authority
FR
France
Prior art keywords
pentaerythritis
tetranicotinate
lipotropic
administration
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR902231A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S PHARMACOTECHNIQUES SOC
Original Assignee
RECH S PHARMACOTECHNIQUES SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH S PHARMACOTECHNIQUES SOC filed Critical RECH S PHARMACOTECHNIQUES SOC
Priority to FR902231A priority Critical patent/FR2046M/fr
Application granted granted Critical
Publication of FR2046M publication Critical patent/FR2046M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR902231A 1962-06-28 1962-06-28 Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration. Expired FR2046M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR902231A FR2046M (fr) 1962-06-28 1962-06-28 Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR902231A FR2046M (fr) 1962-06-28 1962-06-28 Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.

Publications (1)

Publication Number Publication Date
FR2046M true FR2046M (fr) 1963-09-30

Family

ID=87556654

Family Applications (1)

Application Number Title Priority Date Filing Date
FR902231A Expired FR2046M (fr) 1962-06-28 1962-06-28 Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.

Country Status (1)

Country Link
FR (1) FR2046M (fr)

Similar Documents

Publication Publication Date Title
FR3384M (fr) Nouvelle composition pour aérosols pharmaceutiques.
BE772190A (fr) Nouvelles compositions pharmaceutiques
BE823689A (fr) Compositions pharmaceutiques
BE752165A (fr) Preparations pharmaceutiques anesthesiques
BE782981A (fr) Compositions pharmaceutiques
BE817757A (fr) Compositions pharmaceutiques cardiotoniques
BE782444A (fr) Compositions pharmaceutiques
FR3056M (fr) Nouveau médicament pour les malaises hépatiques.
FR3021M (fr) Compositions analgésiques.
BE817427A (fr) Compositions pharmaceutiques
BE764768A (fr) Compositions pharmaceutiques
FR2046M (fr) Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.
BE774033A (fr) Compositions pharmaceutiques anti-allergiques
BE772487A (fr) Compositions pharmaceutiques
FR2285871A1 (fr) Compositions pharmaceutiques
FR1959M (fr) Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration.
FR2116M (fr) Compositions thérapeutiques a action prolongée pour l'administration orale de l'oxy-tétracycline.
BE744083A (fr) Nouvelles preparations pharmaceutiques
FR2557M (fr) Composition pharmaceutique.
BE784835A (fr) Nouvelles preparations pharmaceutiques
FR2501M (fr) Le succinate de di-p.acétaminophénol comme antirhumatismal analgésique antipyrétique et les compositions pharmaceutiques pour son administration.
FR2250M (fr) Composition thérapeutique pour administration orale.
BE757085A (fr) Nouvelles compositions pharmaceutiques
BE775821A (fr) Nouvelles compositions pharmaceutiques a base de thioridazine
FR1940M (fr) Le nicotinate de pyridoxine comme lipotrope, vasodilatateur et eutrophique cutané et les compositions pharmaceutiques pour son administration.